Multiplex Assays Market Analysis, 2018 - 2026

Multiplex Assays Market (Product- Instruments, Consumables (Reagents and Kits, Micropipettes and Microplates), Software; Technology - Multiplex RT-PCR, Flow Cytometry, Fluorescence, Luminescence; Type - Protein (Planar, Bead based), Nucleic Acid (Planar, Bead based), Cell; Application - Research and Development (Drug Discovery and Development, Biomarker Research and Application), Diagnosis (Infectious Diseases, Autoimmune Diseases, Cancer, Cardiovascular Diseases, Neuro-endocrine Diseases); End use - Academic and Research Centers, Diagnostic Centers, Biotechnology and Biopharmaceutical Companies, Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Global Multiplex Assays Market - Snapshot

Multiplex assays can be defined as the type of immunoassay that employs magnetic beads for simultaneously measuring a range of analytes in a single reaction. Multiplex assays are considered to be derivatives of enzyme linked immunosorbent assay (ELISA). However, these are preferred over singleplex ELISA, owing to their advantages such as high throughput, greater output per sample volume, and increased efficiency.

The global multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026, expanding at a CAGR of 7.90% from 2018 to 2026. Expansion of the market can be attributed to the advantages offered by multiplex assays over singleplex assays, rising prevalence of infectious diseases and cancer that can be detected easily at earlier stages, government and private funding for carrying out research, and strategic acquisitions among market players to enhance the reach of the multiplex assay kits. However, the high cost of instruments used to perform multiplex assays, non-availability of diagnostic kits, and lack of skilled labor are anticipated to restrain the market.

In terms of product, the market has been segmented into instruments, consumables, and software. The consumables segment has been further sub-segmented into reagents and kits, microplates and micropipettes, and others. Consumables was the dominant segment in 2017. It is anticipated to remain dominant during the forecast period. It is anticipated to propel at a high CAGR during the forecast period, owing to the significant increase in focus on research and development by major market players, which would lead to repeat orders for consumables, contributing to the rise in revenues. Among the consumables segment, the reagents and kits sub-segment is expected to account for a major share of the consumables segment, in terms of revenue, during the forecast period.

multiplex-assays-market.jpg

Based on technology, the market has been classified into multiplex RT-PCR, flow cytometry, fluorescence, luminescence, and others. The flow cytometry segment dominated the market in 2017. It is anticipated to remain dominant during the forecast period. Robust expansion of the segment can be attributed to the ease of performing multiplex assays through this technology, which offers the flexibility of running a large number of samples simultaneously with accuracy. This, in turn, fuels the segment. Additionally, the focus on development of multiplex bead-based assays for flow cytometers propels the segment.

In terms of type, the market has been segregated into protein, nucleic acid, and cell. The protein segment has been further sub-segmented into planar and bead-based. The nucleic acid segment has been split into planar and bead-based. The protein segment dominated the market in 2017. It is expected to expand at a significant CAGR during the forecast period. Expansion of the segment can be attributed to the increase in analyzing protein samples precisely and simultaneously for dynamic and static as well as predictive, descriptive, and biological research. In terms of protein segment, the bead-based sub-segment is anticipated to remain dominant during the forecast period, owing to its application in the analysis of various infectious diseases and autoimmune diseases.

Based on application, the market has been divided into research & development, diagnosis, and others. The research & development segment has been further segmented into drug discovery & development and biomarker research & application. The diagnosis segment has been further sub-split into infectious diseases, autoimmune diseases, cancer, cardiovascular diseases, neuro-endocrine diseases, and others. The research & development segment is expected to expand at a notable CAGR during the forecast period, due to rise in focus of market players on investments in their research on multiplex assays. Moreover, increasing availability of multiplex kits approved only for research purposes and government and non-government funding for research aid in the growth of the segment.

In terms of end-user, the market has been bifurcated into academic and research centers, biotechnology and biopharmaceutical companies, diagnostic centers, hospitals, and others. The biotechnology and biopharmaceutical companies segment dominated the market in 2017. It is expected to remain lucrative during the forecast period. Expansion of the segment can be attributed to the increase in focus on the establishment of biotechnology companies in emerging economies. Furthermore, increase in the number of biotechnology companies, globally, particularly in Europe and Asia, is expected to boost the segment.

In terms of region, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe, cumulatively, accounted for over 68% of the market. They and are anticipated to remain dominant in terms of revenue during the forecast period. North America is anticipated to remain dominant during the forecast period owing to the presence of leading market players in the region, aiding in the easy and rapid availability of instruments and reagents for conducting assays and the strategic mergers and partnerships among players. The market in Asia Pacific is anticipated to expand at a significant pace during the forecast period. Expansion of the market in the region is expected to be contributed by India and Japan, due to the rise in the geriatric population leading to the increase in prevalence of infectious diseases owing to the weakening immune system.

Key companies operating in the global multiplex assays market include Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.

The global multiplex assays market has been segmented as follows:

by Product

  • Instruments
  • Consumables
    • Reagents & Kits
    • Micropipettes & Microplates
    • Others
  • Software

by Technology

  • Multiplex RT-PCR
  • Flow Cytometry
  • Luminescence
  • Fluorescence
  • Others

by Type

  • Protein
    • Planar
    • Bead-based
  • Nucleic Acid
    • Planar
    • Bead-based
  • Cell

by Application

  • Research & Development
    • Drug Discovery & Research
    • Biomarker Research & Application
  • Diagnosis
    • Infectious Diseases
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Neuro-endocrine Diseases
    • Others
  • Others

by End-user

  • Biotechnology & Biopharmaceutical Companies
  • Academic & Research Centers
  • Diagnostic Centers
  • Hospitals
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of multiplex assays market?

Multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026

What is the anticipated CAGR of the multiplex assays market in the forecast period?

Multiplex assays market is projected to rise at healthy 7.90% CAGR between 2018 and 2026

What are the key driving factors for the growth of the multiplex assays market?

Multiplex assays market is driven by rising use of companion diagnostics to increase the efficacy of therapies

Which is the rising prominent segment in the multiplex assays market?

Consumables was the dominant segment, and it is anticipated to remain dominant during the forecast period

Who are the key players in the global multiplex assays market?

Key players in the global multiplex assays market are Seegene, Inc., Thermo Fisher Scientific, Inc., Abcam plc, Meso Scale Diagnostics, LLC., and Bio-Rad Laboratories, Inc.

    1. Preface
         1.1. Report Scope and Market Segmentation
         1.2. Research Highlights

    2. Assumptions and Acronyms Used

    3. Research Methodology

    4. Executive Summary

    5. Market Overview
         5.1. Product Overview
         5.2. Market Dynamics
                5.2.1. Drivers
                         5.2.1.1. Advantages of multiplex assays over singleplex assays
                         5.2.1.2. Government and non-government funding
                         5.2.1.3. Rise in prevalence of infectious diseases and cancer
                         5.2.1.4. Strategic acquisitions and partnerships
                         5.2.1.5. Increasing applications of multiplex assays
                         5.2.1.6. Significant product launches
                5.2.2. Restraints
                         5.2.2.1. Lack of skilled labor
                         5.2.2.2. High cost of multiplex assay systems
                         5.2.2.3. Constraints of multiplex assays
                         5.2.2.4. Stringent regulatory environment
                         5.2.2.5. Product recalls
                5.2.3. Opportunities
                         5.2.3.1. Rise in focus on multiplexed point-of-care testing
                         5.2.3.2. Combining multiplex assays with microchip arrays
                5.2.4. Trends
                         5.2.4.1. Increase in the number of biotechnology companies
                         5.2.4.2. Growing need for personalized medicine
         5.3. Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016?2026
         5.4. Global Multiplex Assays Market Outlook
         5.5. Key Industry Developments
         5.6. Porter's Five Forces Analysis
         5.7. Comparative Analysis - Multiplex Assays vs Singleplex Assays
         5.8. Comparative Analysis - Planar and Bead-based Multiplex Assays
         5.9. Multiplex Assay – Steps Involved
         5.10. Value Chain Analysis
         5.11. Multiplex Assays – List of Distributors
         5.12. Key Regulatory Agencies
         5.13. Regulatory Approval Process
                5.13.1. U.S.
                5.13.2. Europe
                5.13.3. Asia Pacific
                5.13.4. Latin America
                5.13.5. Middle East & Africa

    6. Global Multiplex Assays Market Analysis, by Product
         6.1. Introduction
         6.2. Key Findings
         6.3. Global Multiplex Assays Market Value Share Analysis, by Product
         6.4. Global Multiplex Assays Market Value Forecast, by Product, 2016?2026
                6.4.1. Instruments
                6.4.2. Consumables
                         6.4.2.1. Reagents & Kits
                         6.4.2.2. Micropipettes & Microplates
                         6.4.2.3. Others
                6.4.3. Software
         6.5. Global Multiplex Assays Market Attractiveness, by Product

    7. Global Multiplex Assays Market Analysis, by Technology
         7.1. Introduction
         7.2. Key Findings
         7.3. Global Multiplex Assays Market Value Share Analysis, by Technology
         7.4. Global Multiplex Assays Market Value Forecast, by Technology, 2016?2026
                7.4.1. Multiplex RT-PCR
                7.4.2. Flow Cytometry
                7.4.3. Luminescence
                7.4.4. Fluorescence
                7.4.5. Others
         7.5. Global Multiplex Assays Market Attractiveness, by Technology

    8. Global Multiplex Assays Market Analysis, by Type
         8.1. Introduction
         8.2. Key Findings
         8.3. Global Multiplex Assays Market Value Share Analysis, by Type
         8.4. Global Multiplex Assays Market Value Forecast, by Type, 2016?2026
                8.4.1. Protein
                         8.4.1.1. Planar
                         8.4.1.2. Bead-based
                8.4.2. Nucleic Acid
                         8.4.2.1. Planar
                         8.4.2.2. Bead-based
                8.4.3. Cell
         8.5. Global Multiplex Assays Market Attractiveness, by Type

    9. Global Multiplex Assays Market Analysis, by Application
         9.1. Introduction
         9.2. Key Findings
         9.3. Global Multiplex Assays Market Value Share Analysis, by Application
         9.4. Global Multiplex Assays Market Value Forecast, by Application, 2016?2026
                9.4.1. Research & Development
                         9.4.1.1. Drug Discovery & Research
                         9.4.1.2. Biomarker Research & Application
                9.4.2. Diagnosis
                         9.4.2.1. Infectious Diseases
                         9.4.2.2. Autoimmune Diseases
                         9.4.2.3. Cancer
                         9.4.2.4. Cardiovascular Diseases
                         9.4.2.5. Neuro-endocrine Diseases
                         9.4.2.6. Others
                9.4.3. Others
         9.5. Global Multiplex Assays Market Attractiveness, by Application

    10. Global Multiplex Assays Market Analysis, by End-user
         10.1. Introduction
         10.2. Key Findings
         10.3. Global Multiplex Assays Market Value Share Analysis, by End-user
         10.4. Global Multiplex Assays Market Value Forecast, by End-user, 2016?2026
                10.4.1. Academic & Research Centers
                10.4.2. Biotechnology & Biopharmaceutical Companies
                10.4.3. Diagnostic Centers
                10.4.4. Hospitals
                10.4.5. Others
         10.5. Global Multiplex Assays Market Attractiveness, by End-user

    11. Global Multiplex Assays Market Analysis and Forecasts, by Region
         11.1. Introduction
         11.2. Regional Outlook
         11.3. Global Multiplex Assays Market Value Forecast, by Region, 2016–2026
                11.3.1. North America
                11.3.2. Europe
                11.3.3. Asia-Pacific
                11.3.4. Latin America
                11.3.5. Middle East & Africa
         11.4. Global Multiplex Assays Market Attractiveness Analysis, by Region

    12. North America Multiplex Assays Market Analysis
         12.1. Key Findings
         12.2. North America Multiplex Assays Market Value Forecast by Country, 2016?2026
                12.2.1. U.S.
                12.2.2. Canada
         12.3. North America Multiplex Assays Market Value Forecast, by Product, 2016?2026
                12.3.1. Instruments
                12.3.2. Consumables
                         12.3.2.1. Reagents & Kits
                         12.3.2.2. Micropipettes & Microplates
                         12.3.2.3. Others
                12.3.3. Software
         12.4. North America Multiplex Assays Market Value Forecast, by Technology, 2016?2026
                12.4.1. Multiplex RT-PCR
                12.4.2. Flow Cytometry
                12.4.3. Luminescence
                12.4.4. Fluorescence
                12.4.5. Others
         12.5. North America Multiplex Assays Market Value Forecast, by Type, 2016?2026
                12.5.1. Protein
                         12.5.1.1. Planar
                         12.5.1.2. Bead-based
                12.5.2. Nucleic Acid
                         12.5.2.1. Planar
                         12.5.2.2. Bead-based
                12.5.3. Cell
         12.6. North America Multiplex Assays Market Value Forecast, by Application, 2016?2026
                12.6.1. Research & Development
                         12.6.1.1. Drug Discovery & Research
                         12.6.1.2. Biomarker Research & Application
                12.6.2. Diagnosis
                         12.6.2.1. Infectious Diseases
                         12.6.2.2. Autoimmune Diseases
                         12.6.2.3. Cancer
                         12.6.2.4. Cardiovascular Diseases
                         12.6.2.5. Neuro-endocrine Diseases
                         12.6.2.6. Others
                12.6.3. Others
         12.7. North America Multiplex Assays Market Value Forecast, by End-user, 2016?2026
                12.7.1. Academic & Research Centers
                12.7.2. Biotechnology & Biopharmaceutical Companies
                12.7.3. Diagnostic Centers
                12.7.4. Hospitals
                12.7.5. Others
         12.8. North America Multiplex Assays Market Attractiveness
                12.8.1. By Country
                12.8.2. By Product
                12.8.3. By Technology
                12.8.4. By Type
                12.8.5. By Application
                12.8.6. By End-user

    13. Europe Multiplex Assays Market Analysis
         13.1. Key Findings
         13.2. Europe Multiplex Assays Market Value Forecast by Country, 2016?2026
                13.2.1. Germany
                13.2.2. U.K.
                13.2.3. France
                13.2.4. Italy
                13.2.5. Spain
                13.2.6. Rest of Europe
         13.3. Europe Multiplex Assays Market Value Forecast, by Product, 2016?2026
                13.3.1. Instruments
                13.3.2. Consumables
                         13.3.2.1. Reagents & Kits
                         13.3.2.2. Micropipettes & Microplates
                         13.3.2.3. Others
                13.3.3. Software
         13.4. Europe Multiplex Assays Market Value Forecast, by Technology, 2016?2026
                13.4.1. Multiplex RT-PCR
                13.4.2. Flow Cytometry
                13.4.3. Luminescence
                13.4.4. Fluorescence
                13.4.5. Others
         13.5. Europe Multiplex Assays Market Value Forecast, by Type, 2016?2026
                13.5.1. Protein
                         13.5.1.1. Planar
                         13.5.1.2. Bead-based
                13.5.2. Nucleic Acid
                         13.5.2.1. Planar
                         13.5.2.2. Bead-based
                13.5.3. Cell
         13.6. Europe Multiplex Assays Market Value Forecast, by Application, 2016?2026
                13.6.1. Research & Development
                         13.6.1.1. Drug Discovery & Research
                         13.6.1.2. Biomarker Research & Application
                13.6.2. Diagnosis
                         13.6.2.1. Infectious Diseases
                         13.6.2.2. Autoimmune Diseases
                         13.6.2.3. Cancer
                         13.6.2.4. Cardiovascular Diseases
                         13.6.2.5. Neuro-endocrine Diseases
                         13.6.2.6. Others
                13.6.3. Others
         13.7. Europe Multiplex Assays Market Value Forecast, by End-user, 2016?2026
                13.7.1. Academic & Research Centers
                13.7.2. Biotechnology & Biopharmaceutical Companies
                13.7.3. Diagnostic Centers
                13.7.4. Hospitals
                13.7.5. Others
         13.8. Europe Multiplex Assays Market Attractiveness
                13.8.1. By Country
                13.8.2. By Product
                13.8.3. By Technology
                13.8.4. By Type
                13.8.5. By Application
                13.8.6. By End-user

    14. Asia Pacific Multiplex Assays Market Analysis
         14.1. Key Findings
         14.2. Asia Pacific Multiplex Assays Market Value Forecast by Country, 2016?2026
                14.2.1. China
                14.2.2. India
                14.2.3. Japan
                14.2.4. Australia
                14.2.5. Rest of Asia Pacific
         14.3. Asia Pacific Multiplex Assays Market Value Forecast, by Product, 2016?2026
                14.3.1. Instruments
                14.3.2. Consumables
                         14.3.2.1. Reagents & Kits
                         14.3.2.2. Micropipettes & Microplates
                         14.3.2.3. Others
                14.3.3. Software
         14.4. Asia Pacific Multiplex Assays Market Value Forecast, by Technology, 2016?2026
                14.4.1. Multiplex RT-PCR
                14.4.2. Flow Cytometry
                14.4.3. Luminescence
                14.4.4. Fluorescence
                14.4.5. Others
         14.5. Asia Pacific Multiplex Assays Market Value Forecast, by Type, 2016?2026
                14.5.1. Protein
                         14.5.1.1. Planar
                         14.5.1.2. Bead-based
                14.5.2. Nucleic Acid
                         14.5.2.1. Planar
                         14.5.2.2. Bead-based
                14.5.3. Cell
         14.6. Asia Pacific Multiplex Assays Market Value Forecast, by Application, 2016?2026
                14.6.1. Research & Development
                         14.6.1.1. Drug Discovery & Research
                         14.6.1.2. Biomarker Research & Application
                14.6.2. Diagnosis
                         14.6.2.1. Infectious Diseases
                         14.6.2.2. Autoimmune Diseases
                         14.6.2.3. Cancer
                         14.6.2.4. Cardiovascular Diseases
                         14.6.2.5. Neuro-endocrine Diseases
                         14.6.2.6. Others
                14.6.3. Others
         14.7. Asia Pacific Multiplex Assays Market Value Forecast, by End-user, 2016?2026
                14.7.1. Academic & Research Centers
                14.7.2. Biotechnology & Biopharmaceutical Companies
                14.7.3. Diagnostic Centers
                14.7.4. Hospitals
                14.7.5. Others
         14.8. Asia Pacific Multiplex Assays Market Attractiveness
                14.8.1. By Country
                14.8.2. By Product
                14.8.3. By Technology
                14.8.4. By Type
                14.8.5. By Application
                14.8.6. By End-user

    15. Latin America Multiplex Assays Market Analysis
         15.1. Key Findings
         15.2. Latin America Multiplex Assays Market Value Forecast by Country, 2016?2026
                15.2.1. Brazil
                15.2.2. Mexico
                15.2.3. Rest of Latin America
         15.3. Latin America Multiplex Assays Market Value Forecast, by Product, 2016?2026
                15.3.1. Instruments
                15.3.2. Consumables
                         15.3.2.1. Reagents & Kits
                         15.3.2.2. Micropipettes & Microplates
                         15.3.2.3. Others
                15.3.3. Software
         15.4. Latin America Multiplex Assays Market Value Forecast, by Technology, 2016?2026
                15.4.1. Multiplex RT-PCR
                15.4.2. Flow Cytometry
                15.4.3. Luminescence
                15.4.4. Fluorescence
                15.4.5. Others
         15.5. Latin America Multiplex Assays Market Value Forecast, by Type, 2016?2026
                15.5.1. Protein
                         15.5.1.1. Planar
                         15.5.1.2. Bead-based
                15.5.2. Nucleic Acid
                         15.5.2.1. Planar
                         15.5.2.2. Bead-based
                15.5.3. Cell
         15.6. Latin America Multiplex Assays Market Value Forecast, by Application, 2016?2026
                15.6.1. Research & Development
                         15.6.1.1. Drug Discovery & Research
                         15.6.1.2. Biomarker Research & Application
                15.6.2. Diagnosis
                         15.6.2.1. Infectious Diseases
                         15.6.2.2. Autoimmune Diseases
                         15.6.2.3. Cancer
                         15.6.2.4. Cardiovascular Diseases
                         15.6.2.5. Neuro-endocrine Diseases
                         15.6.2.6. Others
                15.6.3. Others
         15.7. Latin America Multiplex Assays Market Value Forecast, by End-user, 2016?2026
                15.7.1. Academic & Research Centers
                15.7.2. Biotechnology & Biopharmaceutical Companies
                15.7.3. Diagnostic Centers
                15.7.4. Hospitals
                15.7.5. Others
         15.8. Latin America Multiplex Assays Market Attractiveness
                15.8.1. By Country
                15.8.2. By Product
                15.8.3. By Technology
                15.8.4. By Type
                15.8.5. By Application
                15.8.6. By End-user

    16. Middle East & Africa Multiplex Assays Market Analysis
         16.1. Key Findings
         16.2. Middle East & Africa Multiplex Assays Market Value Forecast by Country, 2016?2026
                16.2.1. GCC Countries
                16.2.2. Israel
                16.2.3. South Africa
                16.2.4. Rest of Middle East & Africa
         16.3. Middle East & Africa Multiplex Assays Market Value Forecast, by Product, 2016?2026
                16.3.1. Instruments
                16.3.2. Consumables
                         16.3.2.1. Reagents & Kits
                         16.3.2.2. Micropipettes & Microplates
                         16.3.2.3. Others
                16.3.3. Software
         16.4. Middle East & Africa Multiplex Assays Market Value Forecast, by Technology, 2016?2026
                16.4.1. Multiplex RT-PCR
                16.4.2. Flow Cytometry
                16.4.3. Luminescence
                16.4.4. Fluorescence
                16.4.5. Others
         16.5. Middle East & Africa Multiplex Assays Market Value Forecast, by Type, 2016?2026
                16.5.1. Protein
                         16.5.1.1. Planar
                         16.5.1.2. Bead-based
                16.5.2. Nucleic Acid
                         16.5.2.1. Planar
                         16.5.2.2. Bead-based
                16.5.3. Cell
         16.6. Middle East & Africa Multiplex Assays Market Value Forecast, by Application, 2016?2026
                16.6.1. Research & Development
                         16.6.1.1. Drug Discovery & Research
                         16.6.1.2. Biomarker Research & Application
                16.6.2. Diagnosis
                         16.6.2.1. Infectious Diseases
                         16.6.2.2. Autoimmune Diseases
                         16.6.2.3. Cancer
                         16.6.2.4. Cardiovascular Diseases
                         16.6.2.5. Neuro-endocrine Diseases
                         16.6.2.6. Others
                16.6.3. Others
         16.7. Middle East & Africa Multiplex Assays Market Value Forecast, by End-user, 2016?2026
                16.7.1. Academic & Research Centers
                16.7.2. Biotechnology & Biopharmaceutical Companies
                16.7.3. Diagnostic Centers
                16.7.4. Hospitals
                16.7.5. Others
         16.8. Middle East & Africa Multiplex Assays Market Attractiveness
                16.8.1. By Country
                16.8.2. By Product
                16.8.3. By Technology
                16.8.4. By Type
                16.8.5. By Application
                16.8.6. By End-user

    17. Competitive Landscape
         17.1. Competition Matrix
         17.2. Company Profiles
                17.2.1. Luminex Corporation
                         17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.1.2. Financial Overview
                         17.2.1.3. Product Portfolio
                         17.2.1.4. SWOT Analysis
                         17.2.1.5. Strategic Overview
                17.2.2. Thermo Fisher Scientific, Inc.
                         17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.2.2. Financial Overview
                         17.2.2.3. Product Portfolio
                         17.2.2.4. SWOT Analysis
                         17.2.2.5. Strategic Overview
                17.2.3. Seegene, Inc.
                         17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.3.2. Financial Overview
                         17.2.3.3. Product Portfolio
                         17.2.3.4. SWOT Analysis
                         17.2.3.5. Strategic Overview
                17.2.4. Meso Scale Diagnostics, LLC.
                         17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.4.2. Product Portfolio
                         17.2.4.3. SWOT Analysis
                         17.2.4.4. Strategic Overview
                17.2.5. Abcam plc
                         17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.5.2. Financial Overview
                         17.2.5.3. Product Portfolio
                         17.2.5.4. SWOT Analysis
                         17.2.5.5. Strategic Overview
                17.2.6. Bio-Rad Laboratories, Inc.
                         17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.6.2. Financial Overview
                         17.2.6.3. Product Portfolio
                         17.2.6.4. SWOT Analysis
                         17.2.6.5. Strategic Overview
                17.2.7. QIAGEN N.V.
                         17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.7.2. Financial Overview
                         17.2.7.3. Product Portfolio
                         17.2.7.4. SWOT Analysis
                         17.2.7.5. Strategic Overview
                17.2.8. Merck KGaA
                         17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.8.2. Financial Overview
                         17.2.8.3. Product Portfolio
                         17.2.8.4. SWOT Analysis
                         17.2.8.5. Strategic Overview
                17.2.9. Quansys Biosciences
                         17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.9.2. Product Portfolio
                         17.2.9.3. SWOT Analysis
                17.2.10. Illumina, Inc.
                         17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                         17.2.10.2. Financial Overview
                         17.2.10.3. Product Portfolio
                         17.2.10.4. SWOT Analysis
                         17.2.10.5. Strategic Overview

    List of Tables

    Table 01: Multiplex Assays– List of Distributors 
    Table 02: Key Regulatory Agencies
    Table 03: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 04: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
    Table 05: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
    Table 06: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 07: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
    Table 08: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
    Table 09: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 10: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
    Table 11: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
    Table 12: Global Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 13: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Region, 2016–2026
    Table 14: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 15: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 16: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
    Table 17: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
    Table 18: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 19: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
    Table 20: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
    Table 21: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 22: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
    Table 23: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
    Table 24: North America Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 25: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 26: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 27: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Product- Consumables, 2016–2026
    Table 28: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
    Table 29: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 30: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
    Table 31: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
    Table 32: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 33: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
    Table 34: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
    Table 35: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 36: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 37: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 38: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
    Table 39: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
    Table 40: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 41: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
    Table 42: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
    Table 43: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 44: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
    Table 45: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
    Table 46: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 47: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 48: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 49: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
    Table 50: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
    Table 51: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 52: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
    Table 53: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
    Table 54: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 55: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
    Table 56: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
    Table 57: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 58: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
    Table 59: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 60: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
    Table 61: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
    Table 62: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
    Table 63: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
    Table 64: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
    Table 65: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 66: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
    Table 67: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
    Table 68: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures 

    Figure 01: Multiplex Assays Market Value (US$ Mn) and Distribution by Geography, 2017 and 2026
    Figure 02: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2018–2026
    Figure 03: Global Multiplex Assays Market Value Share, by Product (2018)
    Figure 04: Global Multiplex Assays Market Value Share, by Technology (2018)
    Figure 05: Global Multiplex Assays Market Value Share, by Type (2018)
    Figure 06: Global Multiplex Assays Market Value Share, by Application (2018)
    Figure 07: Global Multiplex Assays Market Value Share, by End-user (2018)
    Figure 08: Global Multiplex Assays Market Value Share, by Region (2018)
    Figure 09: Porter’s Five Force Analysis
    Figure 10: Steps Involved in Performing Multiplex Assay
    Figure 11: Value Chain Analysis
    Figure 12: U.S. Regulatory Approval Process
    Figure 13: Europe Regulatory Approval Process
    Figure 14: Japan Regulatory Approval Process
    Figure 15: India Regulatory Approval Process
    Figure 16: Latin America Regulatory Approval Process 
    Figure 17: Global Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
    Figure 18: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2016–2026
    Figure 19: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Consumables, 2016–2026
    Figure 20: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Software, 2016–2026
    Figure 21: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Reagents & Kits, 2016–2026
    Figure 22: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Micropipettes and Microplates, 2016–2026
    Figure 23: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 24: Global Multiplex Assays Market Attractiveness, by Product, 2018?2026
    Figure 25: Global Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
    Figure 26: Global Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
    Figure 27: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Multiplex RT-PCR, 2016–2026
    Figure 28: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Flow Cytometry, 2016–2026
    Figure 29: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Luminescence, 2016–2026
    Figure 30: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Fluorescence, 2016–2026
    Figure 31: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 32: Global Multiplex Assays Market Attractiveness, by Technology, 2018?2026
    Figure 33: Global Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
    Figure 34: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Protein, 2016–2026
    Figure 35: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid, 2016–2026
    Figure 36: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cell, 2016–2026
    Figure 37: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Planar, 2016–2026
    Figure 38: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bead-based, 2016–2026
    Figure 39: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Planar, 2016–2026
    Figure 40: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bead-based, 2016–2026
    Figure 41: Global Multiplex Assays Market Attractiveness, by Type, 2018?2026
    Figure 42: Global Multiplex Assays Market Attractiveness, by Protein, 2018?2026
    Figure 43: Global Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
    Figure 44: Global Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
    Figure 45: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research & Development, 2016–2026
    Figure 46: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnosis, 2016–2026
    Figure 47: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 48: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drug Discovery & Development, 2016–2026
    Figure 49: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomarker research & Application, 2016–2026
    Figure 50: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Infectious Diseases, 2016–2026
    Figure 51: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Autoimmune Diseases, 2016–2026
    Figure 52: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cancer, 2016–2026
    Figure 53: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular Diseases, 2016–2026
    Figure 54: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Neuro-endocrine Diseases, 2016–2026
    Figure 55: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 56: Global Multiplex Assays Market Attractiveness, by Application, 2018?2026
    Figure 57: Global Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
    Figure 58: Global Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
    Figure 59: Global Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 60: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic and Research Centers, 2016–2026
    Figure 61: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2016–2026
    Figure 62: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biotechnology and Biopharmaceutical Companies, 2016–2026
    Figure 63: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016–2026
    Figure 64: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 65: Global Multiplex Assays Market Attractiveness, by End-user, 2018?2026
    Figure 66: Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016–2026
    Figure 67: Global Multiplex Assays Market Value Share Analysis, by Region, 2017 and 2026
    Figure 68: Global Multiplex Assays Market Attractiveness, by Region, 2018-2026
    Figure 69: North America Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 70: North America Multiplex Assays Market Attractiveness Analysis, by Country, 2018–2026
    Figure 71: North America Multiplex Assays Market Value Share Analysis, by Country, 2017 and 2026
    Figure 72: North America Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
    Figure 73: North America Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
    Figure 74: North America Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
    Figure 75: North America Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
    Figure 76: North America Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 77: North America Multiplex Assays Market Attractiveness, by Product, 2018?2026
    Figure 78: North America Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
    Figure 79: North America Multiplex Assays Market Attractiveness, by Type, 2018?2026
    Figure 80: North America Multiplex Assays Market Attractiveness, by Protein, 2018?2026
    Figure 81: North America Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
    Figure 82: North America Multiplex Assays Market Attractiveness, by Application, 2018?2026
    Figure 83: North America Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
    Figure 84: North America Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
    Figure 85: North America Multiplex Assays Market Attractiveness, by Technology, 2018?2026
    Figure 86: North America Multiplex Assays Market Attractiveness, by End-user, 2018?2026
    Figure 87: Europe Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 88: Europe Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 89: Europe Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 90: Europe Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
    Figure 91: Europe Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
    Figure 92: Europe Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
    Figure 93: Europe Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
    Figure 94: Europe Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 95: Europe Multiplex Assays Market Attractiveness, by Product, 2018?2026
    Figure 96: Europe Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
    Figure 97: Europe Multiplex Assays Market Attractiveness, by Type, 2018?2026
    Figure 98: Europe Multiplex Assays Market Attractiveness, by Protein, 2018?2026
    Figure 99: Europe Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
    Figure 100: Europe Multiplex Assays Market Attractiveness, by Application, 2018?2026
    Figure 101: Europe Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
    Figure 102: Europe Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
    Figure 103: Europe Multiplex Assays Market Attractiveness, by Technology, 2018?2026
    Figure 104: Europe Multiplex Assays Market Attractiveness, by End-user, 2018?2026
    Figure 105: Asia Pacific Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 106: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 107: Asia Pacific Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 108: Asia Pacific Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
    Figure 109: Asia Pacific Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
    Figure 110: Asia Pacific Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
    Figure 111: Asia Pacific Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
    Figure 112: Asia Pacific Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 113: Asia Pacific Multiplex Assays Market Attractiveness, by Product, 2018?2026
    Figure 114: Asia Pacific Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
    Figure 115: Asia Pacific Multiplex Assays Market Attractiveness, by Type, 2018?2026
    Figure 116: Asia Pacific Multiplex Assays Market Attractiveness, by Protein, 2018?2026
    Figure 117: Asia Pacific Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
    Figure 118: Asia Pacific Multiplex Assays Market Attractiveness, by Application, 2018?2026
    Figure 119: Asia Pacific Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
    Figure 120: Asia Pacific Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
    Figure 121: Asia Pacific Multiplex Assays Market Attractiveness, by Technology, 2018?2026
    Figure 122: Asia Pacific Multiplex Assays Market Attractiveness, by End-user, 2018?2026
    Figure 123: Latin America Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 124: Latin America Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 125: Latin America Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 126: Latin America Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
    Figure 127: Latin America Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
    Figure 128: Latin America Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
    Figure 129: Latin America Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
    Figure 130: Latin America Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 131: Latin America Multiplex Assays Market Attractiveness, by Product, 2018?2026
    Figure 132: Latin America Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
    Figure 133: Latin America Multiplex Assays Market Attractiveness, by Type, 2018?2026
    Figure 134: Latin America Multiplex Assays Market Attractiveness, by Protein, 2018?2026
    Figure 135: Latin America Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
    Figure 136: Latin America Multiplex Assays Market Attractiveness, by Application, 2018?2026
    Figure 137: Latin America Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
    Figure 138: Latin America Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
    Figure 139: Latin America Multiplex Assays Market Attractiveness, by Technology, 2018?2026
    Figure 140: Latin America Multiplex Assays Market Attractiveness, by End-user, 2018?2026
    Figure 141: Middle East & Africa Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 142: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Country/Sub-regions, 2018–2026
    Figure 143: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 144: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
    Figure 145: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
    Figure 146: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
    Figure 147: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
    Figure 148: Middle East & Africa Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 149: Middle East & Africa Multiplex Assays Market Attractiveness, by Product, 2018?2026
    Figure 150: Middle East & Africa Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
    Figure 151: Middle East & Africa Multiplex Assays Market Attractiveness, by Type, 2018?2026
    Figure 152: Middle East & Africa Multiplex Assays Market Attractiveness, by Protein, 2018?2026
    Figure 153: Middle East & Africa Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
    Figure 154: Middle East & Africa Multiplex Assays Market Attractiveness, by Application, 2018?2026
    Figure 155: Middle East & Africa Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
    Figure 156: Middle East & Africa Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
    Figure 157: Middle East & Africa Multiplex Assays Market Attractiveness, by Technology, 2018?2026
    Figure 158: Middle East & Africa Multiplex Assays Market Attractiveness, by End-user, 2018?2026

Copyright © Transparency Market Research, Inc. All Rights reserved